Shukra Pharmaceuticals standalone net profit declines 66.45% in the December 2024 quarter
Net profit of Shukra Pharmaceuticals declined 66.45% to Rs 3.16 crore in the quarter ended December 2024 as against Rs 9.42 crore during the previous quarter ended December 2023. Sales declined 43.99% to Rs 10.58 crore in the quarter ended December 2024 as against Rs 18.89 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 10.58 | 18.89 | -44 |
| OPM % | 37.15 | 50.50 | - |
| PBDT | 4.79 | 10.03 | -52 |
| PBT | 4.09 | 9.52 | -57 |
| NP | 3.16 | 9.42 | -66 |
